Burden of Norovirus and Rotavirus in Children After Rotavirus Vaccine Introduction, Cochabamba, Bolivia.

dc.contributor.authorMcAtee, Casey L
dc.contributor.authorWebman, Rachel
dc.contributor.authorGilman, Robert H
dc.contributor.authorMejia, Carolina
dc.contributor.authorBern, Caryn
dc.contributor.authorApaza, Sonia
dc.contributor.authorEspetia, Susan
dc.contributor.authorPajuelo, Mónica
dc.contributor.authorSaito, Mayuko
dc.contributor.authorChallappa, Roxanna
dc.contributor.authorSoria, Richard
dc.contributor.authorRibera, Jose P
dc.contributor.authorLozano, Daniel
dc.contributor.authorTorrico, Faustino
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-24T15:06:13Z
dc.date.available2026-03-24T15:06:13Z
dc.date.issued2016
dc.descriptionVol. 94, No. 1, pp. 212-7
dc.description.abstractThe effectiveness of rotavirus vaccine in the field may set the stage for a changing landscape of diarrheal illness affecting children worldwide. Norovirus and rotavirus are the two major viral enteropathogens of childhood. This study describes the prevalence of norovirus and rotavirus 2 years after widespread rotavirus vaccination in Cochabamba, Bolivia. Stool samples from hospitalized children with acute gastroenteritis (AGE) and outpatients aged 5-24 months without AGE were recruited from an urban hospital serving Bolivia's third largest city. Both viruses were genotyped, and norovirus GII.4 was further sequenced. Norovirus was found much more frequently than rotavirus. Norovirus was detected in 69/201 (34.3%) of specimens from children with AGE and 13/71 (18.3%) of those without diarrhea. Rotavirus was detected in 38/201 (18.9%) of diarrheal specimens and 3/71 (4.2%) of non-diarrheal specimens. Norovirus GII was identified in 97.8% of norovirus-positive samples; GII.4 was the most common genotype (71.4% of typed specimens). Rotavirus G3P[8] was the most prevalent rotavirus genotype (44.0% of typed specimens) and G2P[4] was second most prevalent (16.0% of typed specimens). This community is likely part of a trend toward norovirus predominance over rotavirus in children after widespread vaccination against rotavirus.eng
dc.description.sponsorshipDepartment of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Department of Surgery, New York University, New York; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland; Laboratorios de Investigación y Desarrollo, Universidad Peruana Cayetano Heredia, Asociación Benéfica PRISMA, Lima, Peru; CEADES Salud y Medio Ambiente, Cochabamba, Bolivia; Department of Epidemiology and Biostatistics, University of California San Francisco, San
dc.identifier.doi10.4269/ajtmh.15-0203
dc.identifier.issn1476-1645
dc.identifier.otherPMID:26598569
dc.identifier.urihttps://doi.org/10.4269/ajtmh.15-0203
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/101216
dc.language.isoeng
dc.relation.ispartofThe American journal of tropical medicine and hygiene
dc.sourcePubMed
dc.titleBurden of Norovirus and Rotavirus in Children After Rotavirus Vaccine Introduction, Cochabamba, Bolivia.
dc.typeArtículo Científico Publicado

Files